Fucoidan-functionalized liposomal nanocarriers for targeted miR-217-5p delivery and combined antitumor treatment in pancreatic ductal adenocarcinoma.

IF 4.3 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Chunlu Tan, Yaohui Fang, Ruizhe Guo, Zhenjiang Zheng, Mingrui He, Jianchen Yang, Epiphane K Silli, Qiqi Hu, Huien Zheng, Yihui Qi, Yuqing Jiang, Shubo Xing, Yanan Sun, Michelle Joycelyn Tyahyo, Qian Li, Ying Wang
{"title":"Fucoidan-functionalized liposomal nanocarriers for targeted miR-217-5p delivery and combined antitumor treatment in pancreatic ductal adenocarcinoma.","authors":"Chunlu Tan, Yaohui Fang, Ruizhe Guo, Zhenjiang Zheng, Mingrui He, Jianchen Yang, Epiphane K Silli, Qiqi Hu, Huien Zheng, Yihui Qi, Yuqing Jiang, Shubo Xing, Yanan Sun, Michelle Joycelyn Tyahyo, Qian Li, Ying Wang","doi":"10.1016/j.nano.2026.103046","DOIUrl":null,"url":null,"abstract":"<p><p>The clinical translation of microRNA (miRNA) therapy is hindered by poor tumor specificity and inefficient delivery. In this study, we constructed a targeted nanoplatform using marine sulfated polysaccharide fucoidan (FU) to encapsulate miR-217-5p in FU-modified cationic liposomes (FU-LIP-miR) for the treatment of pancreatic ductal adenocarcinoma (PDAC), alone or in combination with gemcitabine (GEM). In this system, FU serves primarily as a targeting ligand. FU was incorporated as a functional surface ligand. Previous studies have demonstrated a high-affinity interaction between FU and P-selectin, suggesting that this interaction may contribute to the enhanced tumor-associated accumulation of FU-functionalized nanocarriers. Furthermore, FU is susceptible to degradation by H<sub>2</sub>O<sub>2</sub> within the tumor microenvironment, consequently enabling controlled drug release. Initial findings confirmed that that miR-217-5p was significantly downregulated in PDAC tissues. FU-LIP-miR promoted the tumor accumulation and delivery of miR-217-5p and restored its expression, which was accompanied by reduced PDAC cell proliferation, migration, and invasion. Notably, FU can also be employed as an active targeting ligand. FU-LIP-miR combined with GEM produced an enhanced antitumor effect and increased apoptosis in PDAC cells. In a subcutaneous xenograft model using Panc02 cells in C57BL/6 mice, the combination of FU-LIP-miR and GEM produced enhanced antitumor efficacy compared with the corresponding control treatments. This study underscores the pivotal role of FU as a versatile polysaccharide in the design of targeted delivery platforms, thereby providing a novel and promising noncoding RNA-based therapeutic approach for PDAC using polysaccharide materials.</p>","PeriodicalId":19050,"journal":{"name":"Nanomedicine : nanotechnology, biology, and medicine","volume":" ","pages":"103046"},"PeriodicalIF":4.3000,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine : nanotechnology, biology, and medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.nano.2026.103046","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

The clinical translation of microRNA (miRNA) therapy is hindered by poor tumor specificity and inefficient delivery. In this study, we constructed a targeted nanoplatform using marine sulfated polysaccharide fucoidan (FU) to encapsulate miR-217-5p in FU-modified cationic liposomes (FU-LIP-miR) for the treatment of pancreatic ductal adenocarcinoma (PDAC), alone or in combination with gemcitabine (GEM). In this system, FU serves primarily as a targeting ligand. FU was incorporated as a functional surface ligand. Previous studies have demonstrated a high-affinity interaction between FU and P-selectin, suggesting that this interaction may contribute to the enhanced tumor-associated accumulation of FU-functionalized nanocarriers. Furthermore, FU is susceptible to degradation by H2O2 within the tumor microenvironment, consequently enabling controlled drug release. Initial findings confirmed that that miR-217-5p was significantly downregulated in PDAC tissues. FU-LIP-miR promoted the tumor accumulation and delivery of miR-217-5p and restored its expression, which was accompanied by reduced PDAC cell proliferation, migration, and invasion. Notably, FU can also be employed as an active targeting ligand. FU-LIP-miR combined with GEM produced an enhanced antitumor effect and increased apoptosis in PDAC cells. In a subcutaneous xenograft model using Panc02 cells in C57BL/6 mice, the combination of FU-LIP-miR and GEM produced enhanced antitumor efficacy compared with the corresponding control treatments. This study underscores the pivotal role of FU as a versatile polysaccharide in the design of targeted delivery platforms, thereby providing a novel and promising noncoding RNA-based therapeutic approach for PDAC using polysaccharide materials.

岩藻胶功能化脂质体纳米载体靶向miR-217-5p传递和联合抗肿瘤治疗胰腺导管腺癌。
microRNA (miRNA)治疗的临床翻译受到肿瘤特异性差和递送效率低的阻碍。在本研究中,我们使用海洋硫酸酸化藻多糖(FU)构建了靶向纳米平台,将miR-217-5p包封在FU修饰的阳离子脂质体(FU- lipp - mir)中,用于单独或与吉西他滨(GEM)联合治疗胰腺导管腺癌(PDAC)。在这个系统中,FU主要作为靶向配体。FU作为功能性表面配体掺入。先前的研究表明FU和p -选择素之间存在高亲和力的相互作用,这表明这种相互作用可能有助于增强FU功能化纳米载体的肿瘤相关积累。此外,FU在肿瘤微环境中容易被H2O2降解,从而能够控制药物释放。初步发现证实miR-217-5p在PDAC组织中显著下调。FU-LIP-miR促进了miR-217-5p在肿瘤中的积累和传递,恢复了miR-217-5p的表达,同时PDAC细胞的增殖、迁移和侵袭减少。值得注意的是,FU还可以作为一种活性靶向配体。FU-LIP-miR联合GEM可增强PDAC细胞的抗肿瘤作用,增加PDAC细胞的凋亡。在使用Panc02细胞的C57BL/6小鼠皮下异种移植模型中,FU-LIP-miR和GEM联合使用比相应对照处理具有更强的抗肿瘤效果。本研究强调了FU作为一种多功能多糖在靶向递送平台设计中的关键作用,从而为利用多糖材料治疗PDAC提供了一种新颖而有前途的基于非编码rna的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.10
自引率
0.00%
发文量
133
审稿时长
42 days
期刊介绍: The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书